100 days of isolation to prepare astronauts for long-duration missions

SOLIS100 – studying the effects of isolation on humans

SOLIS100 is an isolation study led by the European Space Agency (ESA) and conducted by the German Aerospace Center (DLR) to investigate the effects of isolation. The study examines the impact of 100 days of isolation, confinement and limited resources on human health, performance and well-being. Held at :envihab – DLR's aerospace medicine research facility in Cologne – SOLIS100 is designed as a ground-based analogue for future long-duration missions to the Moon and Mars.

During the study, six carefully selected participants will live together for 100 days in a closed-off environment. Their daily routine will mirror everyday astronaut activities and involve teamwork, scientific tasks and operational challenges. The findings are expected to help better define the future medical, nutritional and psychological support needs of crew members on long-duration missions and improve preparations for crewed flights to deep space.

Future crewed missions aim to venture beyond low Earth orbit. There are plans for missions to the Moon and Mars, including the establishment of a permanent lunar base. These endeavours present fresh psychological and physical challenges, as they involve long travel times, extended mission durations and increased self-reliance for crew members in isolated, confined environments. Another aspect is that there are no immediate options for rescue in the event of an emergency.

Health impacts of confinement and limited resources

High-quality ground-based analogue studies are essential preparation for space explorers. During a mission, onboard resources are limited and there is little data available from real space flights. Isolation studies have therefore long been used as a form of analogue for space missions to investigate how isolation, confinement and resource limitations affect human health, behaviour and performance. However, current data remains limited, requiring additional research under controlled conditions to better understand the physical and psychological effects of these extreme conditions.

The objective of the SOLIS100 isolation study is to collect standardised data during a 100-day isolation phase so it can be compared with future campaigns at the same facility. In the 2024 SOLIS8 pilot study, which was also conducted in :envihab at the DLR Institute of Aerospace Medicine, researchers tested the facility and the planned structure of a longer isolation study.

The findings gained are now helping to better predict risks, optimise the selection and training of crew members, and devise strategies for maintaining their health and performance during long-duration missions.

News about the SOLIS isolation studies

Loading

SOLIS100 project – effects of 100 days of isolation

  • Duration: 2025 to 2027
  • Lead insitute: DLR Institute of Aerospace Medicine
  • Project type: Core funding
  • Funding body: Third-party funded project commissioned by the European Space Agency (ESA)

Related links